Wonderfeel Youngr NMN (with Resveratrol, TMG & Quercetin) Review

Because the formula is built as a complete longevity stack rather than a single precursor. Resveratrol and quercetin are polyphenols commonly paired with NMN in the longevity space, and TMG (trimethylglycine) is the genuinely thoughtful inclusion: NMN metabolism consumes methyl groups, and TMG is a methyl donor meant to help replenish them. The practical upside is convenience — you're not buying three or four bottles to assemble the same stack. The trade-off is transparency: bundling everything into a 2-capsule serving makes the exact NMN milligram dose less visible than a single-ingredient capsule like Partiqlar (#4), where you know you're getting 500 mg of NMN and nothing else.

The listing states it's physician-developed, but it does not assert an independent certifier seal such as NSF or USP, so we record testing as "None stated" rather than implying one. That's the same honest standard we apply across this lineup — only Elysium Basis (#6, NSF Certified for Sport) and Tru Niagen (#2, ISO/IEC-accredited batch testing) carry genuine independent-certification claims, and both come from their listings. If a named third-party seal is your top priority, those two alternatives are the stronger choice; Youngr's credibility rests on its physician-developed formulation, not on an independent lab certification.

It's the most expensive option in this nine-product lineup at roughly $88 for a 60-capsule bottle that lasts 30 days (the serving is 2 capsules). That works out to about $2.93 per serving — well above commodity single-ingredient NMN like Partiqlar (#4, ~$0.60/capsule) or the budget Double Wood (#7). You're paying for the bundled co-factors and the physician-developed positioning, not just the NMN. Whether that's worth it depends entirely on whether you'd otherwise buy resveratrol, TMG and quercetin separately — if you would, the all-in-one math is far less lopsided.

Mechanistically it's a sensible inclusion. NMN is metabolized through pathways that consume methyl groups, and TMG (betaine) is an established methyl donor, so pairing the two is a rational way to support methylation while supplementing NMN. That said, treat it as a thoughtful formulation choice rather than a proven clinical benefit — there's no trial here showing the combination outperforms NMN alone on any hard outcome. It's a reasonable hedge that a knowledgeable user might add anyway, conveniently built into the capsule.

No — and we'd be doing you a disservice to imply it. Like every NMN product, Youngr should be treated as a promising-but-unproven experiment in your own metabolism, not a longevity guarantee. The human NMN evidence is early and mixed: small trials show oral NMN can raise blood NAD+ and may modestly help surrogate markers like muscle insulin sensitivity, but there is no good evidence it extends human lifespan or reverses aging. The resveratrol-TMG-quercetin co-factors are reasonable longevity-adjacent ingredients, but they don't change that bottom line. Buy it for the convenient complete stack if that appeals, with realistic expectations.

1. [1] Yoshino 2021 PMID 33888596 — Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. In a randomized, placebo-controlled, double-blind trial, 10 weeks of oral NMN (250 mg/day) in postmenopausal women with prediabetes increased muscle insulin sensitivity versus placebo. The most-cited human efficacy signal for NMN — but a surrogate metabolic marker in a small cohort, not evidence of extended lifespan, which Youngr's complete-stack formulation does not change.
2. [2] Fukamizu 2022 PMID 36002548 — Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. A randomized, placebo-controlled trial found oral β-NMN at up to 1,250 mg/day for 4 weeks was safe and well tolerated in healthy adults. Supports the tolerability of NMN — but it is a safety study, not evidence that adding co-factors or any NMN dose produces a longevity benefit.
3. [3] Kimura 2022 PMID 36225528 — Nicotinamide Mononucleotide Is Safely Metabolized and Significantly Reduces Blood Triglyceride Levels in Healthy Individuals. NMN supplementation significantly raised blood NAD+ levels and reduced blood triglycerides in healthy individuals. A human surrogate-marker signal supporting NMN's metabolic plausibility — while still falling short of any hard-outcome or anti-aging proof for NMN or a stacked formula.